BioCep Ltd.

www.biocep.com

High-Tech Company

Suspended Operations Q4/2020

Graduated from: Meytag

TECH VERTICALS

Biologicals, Biotechnology, Life Sciences, MedTech

General Data

Sector	Biomed
Company Stage:	Initial Revenues
Established	2006
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

BioCep develops, manufactures and sells cutting-edge technologies for cell isolation, worldwide. Its Cell Enrichment Process is incorporated in the CEPir (Cell Enrichment Process for Isolation of Rare Cells) cell isolation device, enabling effective immunomagnetic cell isolation for R&D. The CEPir isolates rare cells at high purity and recovery rates offering an alternative to inferior traditional solutions.

TECHNOLOGY

BioCep has developed an advanced platform for cell separation. Its patented Cell Enrichment Process (CEP), yields larger, purer and less damaged cell populations in comparison with existing technologies, setting a new standard in cell separation. The CEP can be applied in numerous medical processes, bringing exceptional benefits to each. BioCep is currently developing applications in non-invasive prenatal testing and stem cell separation, based on its advanced technology.

Products and Phases

Product	Phase
CEPir	Approved
CEPir, is a research use only tool for the effective isolation of rare cell populations. Immunomagnetically tagged cells are captured and held in stasis, as they flow through the unique design. Untagged cells flow through the system and out, enabling depletion as well as positive isolation. Four isolation areas ensure unparallelled recovery of tagged cells.

	TARGET MARKETS
	R&D & Labs, Prenatal Diagnosis Companies.

	BUSINESS MODEL
	B2B

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Patent Attorneys
abC Defghij	Patent Attorneys
abC Defghij	Accounting Firm

CONTACT INFO

Expand / Collapse All

Main Address: Yoqneam Ilit, Israel

Address	13 Hayitzera St.
POB	176
City	Yoqneam Ilit
Country	Israel
Zip	2069200

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Ms. Pazit Enker-Ohana	Сo-CEO
Dr. Ofer Klein	CTO & Co-Founder
Ms. Rachel Leibovitze	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Former CEO, Kitov Pharmaceuticals
abC Defghij	Board Member	General Manager, Rebecca Sieff Hospital

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Third Round

Jun. 01, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Services	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Other	abCDe

Second Round - Extended

Feb. 12, 2014

Initial Revenues

abCDe

Second Round

Jul. 09, 2013

Initial Revenues

abCDe

The investment is subject to milestones.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Services	abCDe
abC Defghij	Private Investor	abCDe	Through H&Co. LP
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Other	abCDe

First Round

Dec. 22, 2008

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Other	abCDe
abC Defghij	Services	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Incubator	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Seed

Jun. 01, 2006

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Investment Company	abCDe
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Services	abCDe
abC Defghij	Incubator	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Oct. 18, 2012

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Bi-Lateral R&D Program	abCDe

R&D Grant

May. 23, 2012

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

May. 24, 2011

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jul. 21, 2010

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 09, 2009

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe